Leonard Schleifer, cofounder and CEO of Regeneron Pharmaceuticals, built one of the most successful biotech companies in the world by combining scientific rigor with long-term investment in research. A trained neurologist turned entrepreneur, he launched Regeneron in 1988 and steered it through decades of discovery to blockbuster drugs such as Eylea, Dupixent, and leading monoclonal antibody therapies. Under his leadership, Regeneron became known for its genetics platform, deep scientific culture, and partnerships that accelerated medical breakthroughs. Schleifer’s blend of clinical expertise, business discipline, and research focus has made him a defining figure in the modern biotechnology landscape.

Marc Coucke, Belgian entrepreneur and investor, built his fortune as the cofounder of Omega Pharma, transforming a small over-the-counter medicine distributor into one of Europe’s largest consumer healthcare companies before selling it to Perrigo for billions. After the sale, Coucke diversified through his investment company Alychlo, acquiring and backing businesses across pharmaceuticals, hospitality, sports, real estate, and leisure—including theme parks, luxury resorts, and the Belgian football club R.S.C. Anderlecht. Known for his charismatic style, bold dealmaking, and expansive portfolio, Coucke has become one of Belgium’s most influential business figures, blending entrepreneurial drive with high-profile investments across Europe.

Jack Schuler, veteran healthcare executive and investor, is best known for his leadership at Abbott Laboratories and Stericycle, where he helped build two of America’s most successful healthcare companies. After serving as president and COO of Abbott, he became CEO of Stericycle, transforming it into a multibillion-dollar medical waste management leader. Later, through his investment firm, he backed numerous biotech and medical device startups, shaping the future of healthcare innovation. A noted philanthropist, Schuler has also supported education and healthcare initiatives through the Schuler Education Foundation.

Glenn Saldanha, chairman and managing director of Glenmark Pharmaceuticals, has guided the India-based company into a global player in generics, specialty medicines, and innovative drug discovery. Since taking leadership in 2001, he has expanded Glenmark’s presence to over 80 countries, strengthened its R&D capabilities, and advanced its pipeline in oncology, dermatology, and respiratory therapies. With a blend of entrepreneurial drive and scientific focus, Saldanha has positioned Glenmark as a respected name in the international pharmaceutical industry while continuing his family’s legacy in healthcare.

Dr. Hao Hong, founder, chairman, and CEO of Asymchem Laboratories, has built the company into a leading global contract development and manufacturing organization (CDMO) serving the pharmaceutical industry. Since establishing the firm in 1997, he has guided its expansion into advanced R&D services, green chemistry solutions, and large-scale manufacturing for biotech and pharma clients worldwide. With a focus on innovation, efficiency, and sustainability, Hong has positioned Asymchem as a key partner in accelerating drug development and advancing healthcare globally.

George Yancopoulos, cofounder, president, and chief scientific officer of Regeneron Pharmaceuticals, is one of the most accomplished scientist-executives in biotechnology. A Columbia-trained physician and molecular immunologist, he helped shape Regeneron’s R&D engine, leading to breakthrough therapies in ophthalmology, immunology, oncology, and infectious disease. Under his guidance, the company developed Eylea, a blockbuster treatment for macular degeneration, and partnered in creating COVID-19 antibody therapies. With hundreds of patents and a reputation for scientific rigor, Yancopoulos has become a driving force behind Regeneron’s rise as a global biotech leader.

Boliang Lou is a Chinese-American entrepreneur, co-founder and CEO of Pharmaron, a leading global contract research and development firm in pharma services established in 2003. A PhD in organic chemistry and former research head at Advanced SynTech, Lou expanded Pharmaron into a multinational enterprise recognized for innovation (e.g., Beijing Overseas Returnee Entrepreneur awards) and strategic partnerships in biotech. 

Dilip Shanghvi is an Indian billionaire businessman, best known as the founder of Sun Pharmaceuticals, the largest pharmaceutical company in India and among the top generic drug makers in the world. His strategic vision and leadership have made significant impacts on the pharmaceutical industry globally.